James T. Willerson, MD
President and Medical Director
Director, Cardiology Research
Co-Director, Cullen Cardiovascular Research Laboratories
Texas Heart Institute
Houston, Texas

Acknowledgement of Support
We acknowledge the following for their support of the live event from which this activity was derived: Biologic Delivery Systems (a division of Cordis Corporation). No grants were received for the production of these online enduring materials.

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Texas Heart Institute designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 1 hour and 15 minutes.

Repurposing Statement
If you previously completed and received credit for the live CME-sponsored symposium entitled, Future Direction of Stem Cells in Cardiovascular Disease on November 7, 2008, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.

Term of Approval
December 16, 2008 through December 16, 2011. Continuation of CME credit from December 16, 2011 depends upon a thorough review of the content for currency and accuracy.

Peer Review
In December 2008, this continuing medical education activity was reviewed for currency and accuracy of content by Patrick J. Hogan, MD, FACC, Director Learning Resource Center and Co-Chairman, Medical Education Committee, Texas Heart Institute, Houston, TX.

Disclosure of Relationships
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.

Faculty Disclosure
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships, either with one or more of the manufacturers of commercial products discussed, or with one or more of the corporate organizations offering educational grants for the live continuing medical education activity.

Stefanie Dimmeler, PhD discloses the following, relevant to this program: Consultant and partnership–t2cure.

Douglas W. Losordo, MD discloses the following, relevant to this program: Consultant–Cordis.

Doris Taylor, PhD discloses the following, relevant to this program: Stockholder–Bioheart, Inc.

James T. Willerson, MD does not have any discloses relevant to this program.

Andreas M. Zeiher, MD discloses the following, relevant to this program: Consultant and stockholder–t2cure; Research grants–Guidant.

In addition, the program director, James T. Willerson, MD, and peer reviewer, Patrick J. Hogan, MD have nothing to disclose relevant to this program.

This enduring material comprises 5 presentations. By clicking on the course materials link below, you acknowledge that you have reviewed the CME information provided above. After viewing all presentations, you must complete an assessment and evaluation to obtain CME credit for this activity.